TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/23/20 17:35 | 3/23/20 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Biolexis Pte Ltd. | U0 | DT | M.d | 0 | 0.00 | 0 | 29,359 | 122 | 53,426 | D | |||||||||||||||
1/29/20 17:53 | 1/29/20 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Biolexis Pte Ltd. | U0 | DT | M.d | 1,081 | 0.2320 | 0 | 4,658 | 27 | 21,606 | D | |||||||||||||||
12/30/19 17:14 | 12/23/19 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Biolexis Pte Ltd. | U0 | DT | M.d | 675 | 0.2320 | 0 | 2,909 | 21 | 16,949 | D | |||||||||||||||
6/19/19 18:18 | 6/17/19 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Biolexis Pte Ltd. | U0 | DT | M.d | 0 | 0.00 | 0 | 2,182 | 18 | 14,039 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |